Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.

@article{Awad2015ClinicalSO,
  title={Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.},
  author={Khaled Thabet Awad and J. P. Griffin and Thomas Christopher Crawford and S Lane Cox and Kevin J. Ferrick and Alexander Mazur and Rafael E Pena and Steven Lloyd and Justin Michalski and Whitney Johnson and William M Bailey},
  journal={Heart rhythm},
  year={2015},
  volume={12 10},
  pages={
          2155-61
        }
}
BACKGROUND Implantable cardioverter-defibrillators (ICDs) are generally considered a contraindication to magnetic resonance imaging (MRI). OBJECTIVE The purpose of the ProMRI Phase C study, a multicenter, prospective, single-arm, nonrandomized study, was to evaluate the clinical safety of the Biotronik ProMRI Iforia ICD system during MRI. METHODS Patients were enrolled after ICD implantation, with either a dual-chamber DR-T or single-lead VR-T DX system. Study-defined, nondiagnostic cardiac… CONTINUE READING
BETA